Navigation Links
Cepheid to Present at ThinkEquity Partners 5th Annual Growth Conference
Date:9/11/2007

SUNNYVALE, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) will present at the ThinkEquity Partners 5th Annual Growth Conference at the St. Regis Hotel, San Francisco, on Sept. 17, 2007. Chief Executive Officer John L. Bishop and Chief Financial Officer, John Sluis will present at 9:30 a.m. PDT.

There will be a live audio webcast of the presentation, along with accompanying presentation slides, available on Cepheid's Web site at http://www.cepheid.com under Investors: Events: Webcasts and Presentations. A replay of the webcast presentations will be available for 90 days following the event.

About Cepheid

Cepheid (Nasdaq: CPHD), based in Sunnyvale, California, is a molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the clinical, industrial and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See '/>"/>

SOURCE Cepheid
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , PRINCETON, NJ, Nov. 20 /PRNewswire-FirstC...ay that a Special Meeting of Shareholders will be ...the Meeting is to consider approval of two special...pprove and authorize the sale of all or substantia... the terms provided for in the asset purchase agre...
(Date:11/20/2009)... Senators and Congressmen in...le Over their Health Care Vote , ...- Senators and congressmen running for re-election...litical guru Charlie Cook, may come to regret voti...are bill, according to a breaking Zogby Internatio...
(Date:11/20/2009)... , HAIFA, Israel, November 20 /PRNewsw...orp. (CVSL.OB), http://www.CVSLMEDICAL.COM , a le... technology, today announced that,the company,s Bo...plications,in Europe, Canada and the Far East for ...re" applicable for all angioplasty (PCTA) procedur...
(Date:11/20/2009)...n editorial published online November 20 in the J... the exaggerated fears and hopes that often appear...l provides guidance for both the media and journal...rtz, M.D., M.S., and Steven Woloshin, M.D., M.S., ...uth Institute for Health Policy and Clinical Pract...
(Date:11/20/2009)... Based out of Dallas, TX, th...same quality products that are made in the USA. ,...er 20, 2009 -- blue sky scrubs is an independent m... quality, design, production and distribution of h...ly only selling their products via their online bo...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Blue Sky Scrubs Secures a Second Texas Manufacturer 2
...April 21 MedCath Corporation,(Nasdaq: MDTH ) ann...econd,quarter of fiscal 2008, which ended March 31...iscal 2008 outlook. MedCath,s preliminary earnings...nounced on March 24, 2008 that it had entered into...
...ess to feature U.S. Health and Human Services Secr... for value-based health system;, Event to convene...s the health care industr...r U.S. Presidential candidates Sen. Barack Obama, ...
..., April 21 As the pace of global,competition hast...earch,groups to keep up. Effective market research...tion by using customers, markets and competitors a... research groups are able to deliver,forward-looki...
... may exist in observational studies that compare o...results questionable. That is the conclusion of a...CANCER, a peer-reviewed journal of the American Ca...curacies. , Clinical trials are considered the go...
...search supported by the Canadian Cancer Society sh...eight and inactive, which could put them at risk f...ng. , These findings tell us that we need to loo...a Research Chair at the University of Alberta in E...
...allergen species, avoiding high pollen hours can h...-- For gardeners with allergies, it can be difficu...e to cope with the misery of sneezing, itchy eyes,...mptoms," Dr. Warren Filley, an allergist/immunolog...
Other Medicine News:Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 2Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 3Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 4Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 5Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 6Health News:MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook 7Health News:5th Annual World Health Care Congress Kicks off April 21 With Obama, Clinton, McCain Health Care Policy Advisor Presidential Health Care Agenda Forum 2Health News:Creating an Effective Market Research Group to Generate High-Impact Business Results 2Health News:Study reveals inaccuracies in studies of cancer treatment 2Health News:Obesity, inactivity as common among cancer survivors as rest of Canadians, study shows 2Health News:Obesity, inactivity as common among cancer survivors as rest of Canadians, study shows 3Health News:Allergies Can Dig Into Gardening's Fun 2
(Date:11/19/2009)... , BIRMINGHAM, Ala., Nov. 19 /PRNewswire-First...BCRX ) today announced the pricing of a public off...9.75 per share, resulting in gross proceeds of $48...by BioCryst pursuant to an effective shelf registr...es and Exchange Commission. BioCryst has also gra...
(Date:11/19/2009)..., MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswire-Fi... ALXA ) announced today that its corporate present...Piper Jaffray Health Care Conference on Wednesday,...presentation will be webcast from The New York Pal...mas B. King, Alexza President and CEO. ,, To ...
(Date:11/19/2009)... , NEW YORK, Nov. 19 As the s...g noses is here. Here,s more on preparing yourself...nssen Pharmaceuticals Inc. at: ,, http://inr...bxc9R2VXAOIF ,, Medialink is a division of T...video, audio, text, graphics and photos at http:...
Breaking Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Researchers notch a victory toward new kind of cancer drug 61165 1Researchers notch a victory toward new kind of cancer drug 61165 2Researchers notch a victory toward new kind of cancer drug 61165 3Drug industry nonprofits join forces to fight worlds neglected diseases 61163 1AAAS exhibit featuring photographs of climate change opens Nov 18 10697 1AAAS exhibit featuring photographs of climate change opens Nov 18 10697 2AAAS exhibit featuring photographs of climate change opens Nov 18 10697 3
...High Concentrations Reached in Key Lung Compartmen...,/PRNewswire-FirstCall/ -- Arpida Ltd. today annou...ith AR-709. These radiolabelled,Human Microdose st...rs. , This groundbreaking study is the first ever ...ncentrations in lung compartments.,The results sho...
... DEERFIELD, Ill., March 29, 2007 /PRNewswire-First... final Phase I/II data for its,adjuvant-free inves...ns to initiate a Phase III clinical trial of the c...sults. , The Phase I/II study indicated that Baxte...t low doses, and induces substantial,levels of cro...
Other Medicine Technology:Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 2Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 3Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 5Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 2Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 3Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 4Baxter Announces Final Phase I/II Data and Initiation of Phase III,Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine 5
Cushing Periosteal Elevator
Adson Periosteal Elevators
Ohl Periosteal Elevators
Seldin Periosteal Elevators
Medicine Products: